A recent ASH study highlights the impact of CAR T and bispecific therapies on patient time commitment and quality of life in ...
Explore the operational challenges and solutions in administering bispecific therapies for follicular lymphoma, focusing on ...
Explore the vital role of interprofessional teams in primary care for managing chronic kidney disease and enhancing patient ...
Explore the promising results of the REDIRECT trial, combining bispecific therapies for treating relapsed/refractory myeloma ...
Explore innovative strategies for enhancing population health through quality measures, clinician collaboration, and ...
Advances in Personalized Actinic Keratosis, Nonmelanoma Skin Cancer Treatments: Paul Nghiem, MD, PhD
Paul Nghiem, MD, PhD, discusses individualized therapies and the evolving role of AI in improving outcomes for actinic keratosis and related skin conditions.
The CDC announced that recommendations for vaccines for respiratory syncytial virus, hepatitis A, hepatitis B, dengue, and 2 types of bacterial meningitis were rolled back. 2 The vaccinations for flu, ...
Objectives: To estimate the prevalence of ambient artificial intelligence (AI) documentation tool adoption among US hospitals using Epic electronic health record (EHR) s ...
Incorporating patient-reported outcome measures, such as quality of life, as well as looking into real-world data, is ...
Angiotensin-converting enzyme (ACE) inhibitors were found to be independently associated with reducing all-cause mortality in ...
Colorectal cancer (CRC) became the leading cause of cancer -related deaths in 2023 among patients aged younger than 50 in the ...
Rocatinlimab, targeting the OX40 pathway, shows significant efficacy in moderate to severe atopic dermatitis, marking a new therapeutic class in disease management. Long-term melanoma data reveal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results